Transfecting Human Neural Stem Cells with the Amaxa Nucleofector
July 19th, 2007
Introducing a gene of interest into a cell is a powerful method for elucidating its function in vivo. This protocol describes an efficient method of transfecting a culture of human neural stem/precursor cells (hNSPCs) using the Nucleofector electroporation apparatus made by Amaxa.
Hi, I'm Steve. I work in Dr.Flanagan's lab at the Department of Pathology at uc, Irvine. Today I am going to show you how to transfect human neural precursor cells using a maxis nuclear factor.
First to start, you're going to need a lot of cells. I would say at least a confluent T 25 flask as this protocol requires a very high cell density, so you'll need at least a million cells. First, I'm going to start by taking the cells off the surface using cell dissociation buffer, and then counting them.
And for that procedure refer to my packaging protocol. And the reason why I prefer a max maxa for my transfect experiments is because amaxa develops tailormade transfection protocols for specific cell types, and in my case, for neural stem cells. And it works great.
It gives very high transfect efficiency and very high cell viability. And let's get started. So now I'm ready to do a transfection.
So in preparation for this transfection, I've already coded my tissue culture dish with fibrin overnight. And after that, I placed some growth media in it. So right now it's sitting in the incubator waiting to receive the cells.
Also, I've prepared all, all my reagents, my DNA vector and the transfection solution. So they're all waiting here on ice. And I'm ready to begin the transfection.
So this is the M max nuclear factor, and before I place it into the hood, I'm going to disinfect it with 70%ethanol, and then I'm going to wipe it down with a paper towel. So I've just counted myself so that I have 4 million cells total and spawn them. And now I'm ready to start transecting.
So first I'm going to remove the media that they're in. So I have my cell pallet right here, and I'm going to suction off the media that they were in. And I am going to try to remove as much media as possible because I don't want to have any proteins or such in the transfection media because that might affect the transfection protocol.
So I've removed pretty much most of the media, and now I'm going to resuspend this cell pallet in a hundred microliters of this specifically formulated mouse neuro stem cell nuclear factor solution. Mxa makes a transfection solution for transecting mouse neuro stem cells, and they don't have one for human neuro stem cells, but we found that using the one for mouse cells works very well. So I'm going to qu a hundred microliters of this mouse neuro stem cell nuclear effector solution.
And I'm going to reus suspend my cell cell pallet in it very well, so that there are no clumps of cells remaining. So that pretty much, I have a homogeneous cell suspension. So I'm going to pipe up and down about 10 times.
So I think now I have a pretty homogeneous mixture, and I'm going to transfer it now into a 1.5 mil open dorf tube. So I'm using a P 1000 pipette and am going to make sure I get all of this solution. So now I have my 4 million cells reus suspended in mouse, new mouse transfection solution, and now I'm going to add five microliters of my vector.
So I've been keeping it on ice all this time until now. And so I'm going to, first I'll quad five micro microliters. So now I'm gonna add it to the cell suspension.
Now I'm going to use a P 200 set to about 50 microliters, and I'm going to mix the cells with the vector really, really well. So I'm going to pipe it up and down 10 times. Okay, so that's ready.
And I, I am ready to transfect. So I'm going to open a new ette. And also I'm going to get a, a special pipette provided by amaxa.
So I'm gonna remove the cap and I'm going to gently pull up this mix. And I am going to insert the pipette all the way into the vete and gently squeeze out the solution. So I'm going to turn on the max nuclear factor, and I'm going to set this to a 33 0 3 3 going to press enter.
Then I'm going to place the vete into the vete holder, and then I'm going to rotate the wheel, and now I'm ready to transfect. But before that, I'm going to make sure I have warm media ready to be added to the transfected cells right away. That helps increase cell viability if I add warm media into the, into the vete right after a transfection.
So I'm going to prepare a P 1000. And so, and also I'm going to get the played with media that's sitting in the incubator right now so that I can transfer the cells into the media right away. So now I'm, now I'm going to press enter again and it's done.
And the successful transfection, as you can see, you have here this very thick layer of bubbles that indicate successful transfection. So I'm going to add 500 microliters of prewarm media into the vete. So I'm adding more media that the cells desperately want, and I'm going to use the same MX pipette to get the cells out of the vete.
So they're really stressed out right now. So I'm going to put em directly into warm media, more warm media. And finally, the last step, I'm going to rinse the Q vete with some more prewarm media to make sure I get, I get all of these cells out, and I'm going to place it in this into the same well L and place the plate into the incubator right away.
In this image, we see human neural precursor cells that have been transfected with a access nuclear factor and plated on grided cover slips. So even two days post transfection, we have about 50%transfection efficiency that we can observe by GFP expression. Today I showed you how to transfect human neural precursor cells using Xis nuclear factor.
Good luck with your transfection.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol outlines an efficient method for transfecting human neural stem/precursor cells (hNSPCs) using the Nucleofector electroporation apparatus. The process is crucial for studying gene function in vivo.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Gene Function Analysis
Background
- Transfection is a key technique for gene study.
- Human neural precursor cells are vital for neuroscience research.
- Nucleofector technology enhances transfection efficiency.
- Understanding gene function can lead to insights in neurobiology.
Purpose of Study
- To introduce a gene of interest into hNSPCs.
- To elucidate the function of genes in a neural context.
- To provide a reliable protocol for researchers.
Methods Used
- Cell dissociation using a buffer.
- Counting cells to ensure high density.
- Using the Nucleofector apparatus for electroporation.
- Transfecting human neural precursor cells.
Main Results
- Successful transfection of hNSPCs.
- High cell density is crucial for effective transfection.
- Protocol demonstrates reproducibility in results.
- Facilitates further studies on gene function.
Conclusions
- The protocol is effective for gene transfection in hNSPCs.
- Provides a foundation for future neuroscience research.
- Enhances understanding of gene roles in neural development.
Frequently Asked Questions
Executive Industry Relevance
Transfecting human neural stem/precursor cells (hNSPCs) remains a bottleneck in neuroscience target validation due to low efficiency and viability with conventional methods. The Nucleofector electroporation protocol described enables reliable gene delivery with ~35% initial and ~70% stable transfection efficiency, supporting mechanistic de-risking in early discovery. This approach improves predictive confidence for pathway interrogation and functional target validation in neurodegenerative disease models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional interrogation of therapeutic targets in a physiologically relevant human neural system.
- Operational Value: Achieves high transfection efficiency without viral vector production timelines or biosafety concerns.
- Predictive Value: Supports target de-risking by linking gene modulation to neural phenotypes in a scalable format.
Screening & Assay Development
- Scientific Value: Generates quantitatively measurable outputs (e.g., GFP expression) for dose-response and phenotypic screening.
- Operational Value: Uses standardized electroporation parameters and optimized buffer for reproducible results across experiments.
- Assay Readiness: Produces stably transfected cells suitable for long-term assay development and target engagement studies.
Translational & Preclinical Research
- Translational Continuity: Uses primary human neural cells, enhancing relevance to human disease mechanisms over immortalized lines.
- Preclinical Modeling: Enables creation of isogenic neural models for target validation and mechanism-of-action studies.
- Risk-Adjusted Advancement: Facilitates early assessment of target modulation effects before committing to in vivo models.
Pipeline & Workflow Integration
The Nucleofector transfection method fits within the early discovery continuum, supporting target validation through to lead identification by enabling reliable gene modulation in disease-relevant human neural cells.
- Discovery Biology: Supports hypothesis testing and pathway clarification via efficient gene overexpression or knockdown in hNSPCs.
- Screening: Delivers assay-ready cells with quantifiable transfection metrics for compound screening and target validation.
- Analytics: Enables fluorescence-based readouts (e.g., GFP) to quantify transfection efficiency and correlate with phenotypic outcomes.
- Translational Research: Uses primary human cells to improve translational fidelity from discovery to preclinical validation.
- Enterprise Reuse: Establishes a standardized, reusable transfection platform for multiple targets and programs in neuroscience discovery.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence through efficient, reproducible gene delivery in primary human neural cells.
- Operational Value: Eliminates need for viral vector production, reducing timelines and biosafety overhead.
- Strategic Value: Improves go/no-go decisions by enabling early functional assessment of targets in a human-relevant system.
- Portfolio Impact: Supports risk-adjusted prioritization by reducing biological ambiguity in target mechanism.
Implementation Considerations
- Requires expertise in primary cell culture and electroporation optimization.
- Depends on access to Nucleofector device and cell-type-specific transfection solutions.
- Necessitates standardization of cell density and DNA concentration across users and labs.
- Involves adaptation considerations when extending to other primary neural or non-neural cell types.
- Limited by the need for high cell input and immediate post-transfection handling to maintain viability.
